CRIS Current Research Information System

GENTILUCCI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.092
EU - Europa 5.717
AS - Asia 2.466
AF - Africa 470
SA - Sud America 12
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.073
IT - Italia 1.838
GB - Regno Unito 1.430
CN - Cina 1.035
DE - Germania 652
SG - Singapore 550
VN - Vietnam 434
SE - Svezia 379
UA - Ucraina 368
IN - India 256
FR - Francia 239
IE - Irlanda 225
TG - Togo 205
RU - Federazione Russa 190
ZA - Sudafrica 110
CI - Costa d'Avorio 100
BG - Bulgaria 91
EE - Estonia 87
JO - Giordania 67
CH - Svizzera 52
BE - Belgio 34
HK - Hong Kong 28
SC - Seychelles 26
NG - Nigeria 25
HR - Croazia 24
JP - Giappone 20
FI - Finlandia 19
ES - Italia 18
CA - Canada 17
IR - Iran 16
LB - Libano 16
RO - Romania 15
NL - Olanda 13
AT - Austria 9
AU - Australia 9
PK - Pakistan 9
CL - Cile 8
GR - Grecia 8
TR - Turchia 8
PL - Polonia 7
EU - Europa 6
CZ - Repubblica Ceca 5
IL - Israele 4
IQ - Iraq 4
PT - Portogallo 4
BD - Bangladesh 3
BR - Brasile 3
NO - Norvegia 3
SI - Slovenia 3
TH - Thailandia 3
TN - Tunisia 3
ID - Indonesia 2
MX - Messico 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MW - Malawi 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 14.773
Salva come PNG Salva come JPEG
Città #
Southend 1.248
Fairfield 768
Chandler 604
Ashburn 512
Singapore 449
Woodbridge 375
Bologna 349
Wilmington 339
Seattle 336
Princeton 300
Cambridge 285
Houston 283
Ann Arbor 265
Dong Ket 264
Jacksonville 262
Dublin 217
Lomé 205
Nanjing 150
Padova 131
Westminster 131
Milan 108
Abidjan 100
Berlin 98
Sofia 91
Jinan 82
Beijing 80
Santa Clara 75
Amman 67
Shenyang 67
Saint Petersburg 64
Bremen 61
Hebei 50
Medford 49
Mülheim 46
San Diego 45
Changsha 42
Turin 42
Redmond 40
Nanchang 37
Shanghai 36
New York 35
Tianjin 34
Guangzhou 33
Brussels 32
Haikou 31
Hangzhou 29
Rome 29
Zhengzhou 29
Des Moines 27
Mountain View 27
Boardman 26
Mahé 25
Abeokuta 24
Redwood City 24
Forlì 23
Los Angeles 23
Wuhan 22
Cesena 21
Bari 19
Jiaxing 19
Norwalk 19
Falls Church 17
Modena 17
Boydton 16
Florence 16
Forlimpopoli 16
Pessac 16
San Mauro Pascoli 16
Tokyo 16
Helsinki 15
Ningbo 15
San Venanzo 15
Taizhou 15
Zurich 15
Chicago 14
Verona 14
Dearborn 13
Kunming 13
Shenzhen 13
Bern 12
Davis 12
Fremont 12
Imperia 12
Paris 12
Parma 12
Taiyuan 12
Hong Kong 10
Lanzhou 10
London 10
Olalla 10
Pune 10
Bühl 9
Naples 9
Ravenna 9
Venezia 9
Washington 9
Chengdu 8
Luisago 8
Moscow 8
Wuppertal 8
Totale 9.787
Salva come PNG Salva come JPEG
Nome #
Inibitori dei processi infiammatori cronici connessi allo sviluppo di tumori (Inhibitors of the chronic inflammatory processes connected to tumor development) 571
Targeting integrins αvβ3 and α5β1 with new β-lactam derivatives 181
Dehydro-beta-proline Containing Alpha-4-beta-1 Integrin Antagonists: Stereochemical Recognition in Ligand-Receptor Interplay 178
A novel family of minimal PMRI cyclic peptides as versatile scaffolds for generating new molecular topology. 176
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration 176
A simple route towards peptide analogues containing substituted (S)- or (R)-tryptophans 167
Thixotropic peptide-based physical hydrogels applied to three-dimensional cell culture 166
A novel family of minimalist opioid peptides deprived of the classic pharmacophores 164
Constraining Endomorphin-1 by β,α-Hybrid Dipeptide/Heterocycle Scaffolds: Identification of a Novel κ-Opioid Receptor Selective Partial Agonist 161
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists 159
Modern tools for the chemical ligation and synthesis of modified peptides and proteins 158
A convenient synthesis of functionalized isoxazolines and related 5-hydroxy-isoxazolidine-4-carboxylates 157
A microwave-enhanced, Lewis acid-catalyzed synthesis of 1,3-dioxolanes and oxazolines from epoxides 148
Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization 143
Ac-D-Trp-PheNH2 AND Ac-D-Trp-Phe-GlyNH2 - A NEW CLASS OF UNUSUAL OPIOID PEPTIDES 137
DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs 137
Antiangiogenic Effect of Dual/Selective α5β1/αvβ3 Integrin Antagonists Designed on Partially Modified Retro-Inverso Cyclotetrapeptide Mimetics 135
A straightforward route to enantiopure 2-substituted-3,4-dehydro-beta-proline via ring closing metathesis 134
Practical synthesis of 3-bromo-5,6-dihydropyridin-2-ones via β,γ-unsaturated α-bromo-ketene/imine cycloaddition 130
Highly Regio- and Diastereoselective Palladium-Catalyzed Allylic Substitution. Synthesis of 3-(2-aminobutylidene)-4-arylazetidin-2-ones 129
Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity? 129
An improved microwave assisted protocol for Yonemitsu-type trimolecular condensation 128
An investigation of the reactivity of MCPBA and alpha-bromoalkenes under traditional or microwave-assisted conditions: Selective formation of epoxides or allylic bromides. 128
Asymmetric Synthesis of three and four membered ring heterocycles 127
Controlling Cyclopeptide Backbone Conformation with β/α-Hybrid Peptide–Heterocycle Scaffolds 126
Diagnostic implementation of fast and selective integrin-mediated adhesion of cancer cells on functionalized zeolite L monolayers 125
DESIGN AND SYNTHESIS OF OPIOID PEPTIDE ANALOGUES AND MIMETICS 125
Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist 125
alpha-Bromo-beta,gamma-unsaturated Ketenes as Valuable Intermediates in the Synthesis of alpha-Amino-beta,gamma-Unsaturated Acids 123
Exploring the reactivity of alkylidene malonamides: synthesis of polyfunctionalized isoxazolidinones, aziridines and oxazolines 123
Green synthesis of bioactive oligopeptides promoted by recyclable nanocrystalline hydroxyapatite 123
Convenient Synthesis of the Antibiotic Linezolid via an Oxazolidine-2,4-dione Intermediate Derived from the Chiral Building Block Isoserine 123
Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects 123
Zinc Metal-Promoted Nucleophilic Addition of Azetidin-2-ones to Aldehydes and Nitriles 122
New trends in the development of opioid peptide analogues as advanced remedies for pain relief 120
Opioid Activity Profiles of Oversimplified Peptides Lacking in the Protonable N-Terminus 118
Integrin-targeting dye-doped peg-shell/silica-core nanoparticles mimicking the proapoptotic Smac/DIABLO protein 118
Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation 117
Dehydro-beta-amino Acid Containing Peptides as Promising Sequences for Drug Development 116
A new generation of opioid peptidomimetics acting as central and/or peripheral analgesics 116
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 116
Synthesis and evaluation of the affinity toward mu-opioid receptor of atypical, lipophilic ligands based on the sequence c[Tyr-Pro-Trp-Phe-Gly-]. 114
Synthesis and Biological Evaluation of Azido- and Aziridino-hydroxyl-beta -lactams through Stereo- and Regioselective Epoxide Ring Opening. 114
Design of α/β-hybrid peptide ligands of α4β1 integrin equipped with a linkable side chain for chemoselective biofunctionalization of microstructured materials 114
Modulation of αvβ3- and α5β1-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics 112
The Inverse Type II β-Turn on D-Trp-Phe, a Pharmacophoric Motif for MOR Agonists. 111
Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics. 111
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions 111
Highly regio- and stereoselective palladium-catalyzed allylic carbonate amination. A practical route to dehydro-beta-amino esters 110
Enzymatic Resolution of Ethyl 3-Hydroxy-2(1'substituted-methylidene)-butyrate by Pseudomonas Cepacia Lipase Catalyzed Acetylation 110
Asymmetric Synthesis of Three and Four Membered Ring Heterocycles - Chapter 1 109
Synthesis and assay of retro-α4β1 integrin-targeting motifs 109
Topological exploration of cyclic endomorphin-1 analogues, structurally defined models for investigating the bioactive conformation of MOR agonists. 108
Synthesis of dehydro-beta-amino esters via highly regioselective amination of allylic carbonates 108
Cyclotetrapeptide Mimics based on a 13-Membered, Partially Modified Retro-Inverso Structure 108
In-peptide synthesis of di-oxazolidinone and dehydroamino acid-oxazolidinone motifs as β-turn inducers 108
Development of isoxazoline-containing peptidomimetics as dual alpha-v-beta-3 and alpha-5-beta-1 integrin ligands. 106
Lewis acid induced highly regioselective synthesis of a new class of substituted isoxazolidines 106
Controlled solid phase peptide bond formation using N-carboxyanhydrides and PEG resins in water. 106
Highly Diastereoselective Allylic Azide Formation and Isomerization. Synthesis of 3(2'-Amino)-beta-lactams 105
Synthesis and Biological Evaluation of Nonpeptide alpha-v-beta-3/alpha-5-beta-1 Integrin Dual Antagonists containing 5,6-Dihydropyridin-2-one Scaffolds 105
null 105
Unusual Amino Acids: Synthesis and Introduction into Naturally Occurring Peptides and Biologically Active Analogues 104
Investigation of the Interaction Between the Atypical Agonist c[YpwFG] and MOR 104
Cyclopeptide analogs for generating new molecular and 3D diversity 102
Heterocyclic Scaffolds in the Design of Peptidomimetic Integrin Ligands: Synthetic Strategies, Structural Aspects, and Biological Activity 101
Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-d-alanine 98
Design and characterization of opioid ligands based on cycle-in-macrocycle scaffold 98
Dehydro-beta-amino acids as scaffolds for the preparation of alpha-v-beta-3, alpha-5-beta-1 and alpha-4-beta-1 integrin ligands 97
Synthesis of Ethyl 5-Hydroxyisoxazolidine-4-carboxylates via Michael Addition/Intramolecular Hemiketalisation 97
Synthesis of chiral non-racemic intermediates and Arg-Gly-Asp mimetics by CaLB-catalyzed resolution 97
Peptide bond formation using unprotected N-carboxyanhydrides under green chemistry conditions 97
Peptides and peptidomimetics in medicine, surgery, and biotecnology 96
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 95
Versatile Picklocks to Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe- d -Pro-Phe-Trp] (CJ-15,208) 95
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects 93
null 93
NEW PEPTIDOMIMETIC α4β1-INTEGRIN ANTAGONISTS FOR REDUCING INFLAMMATION AND ALLERGIC REACTIONS 93
Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief 93
Current Medicinal Chemistry 92
Atypical mu-opioid agonists: reconsideration of the requisites for receptor activation 92
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 92
Functionalizations of the C3 side chain of densely substituted azetidin-2-ones 91
Stereoselective synthesis of a new class of spiro-beta-lactams via epoxide ring opening 91
DETERMINATION OF THE BIOLOGICALLY ACTIVE STRUCTURE OF THE ATYPICAL MOR-LIGAND c[D-Asp-1-amide-beta-Ala-D-Trp-Phe] AND ANALOGUES BY NMR AND MOLECULAR DOCKING 90
Synthesis and biological evaluation of unprecedented classes of spiro-beta-lactams and azido-beta-lactams as acyl-CoA:cholesterol acyltransferase inhibitors 89
Design and synthesis of Alpha-v-beta-3 and Alpha-5-beta-1 integrin ligands as delivery systems for fluorescent molecules 89
One-Pot Synthesis of Poly-Substituted Tetramic Acids for the Preparation of Reverse-Turn Mimics 88
Synthesis of Enantiomerically Pure alpha-v-beta-3 Integrin ligands Based on a 5,6-Dihydropyridin-2-one Scaffold. 88
Preparation of Non-Toxic Fluorescent Peptide-Coated Silica/PEG Nanoparticles from Peptide-Block Copolymer Conjugates 87
Synthesis of Constrained Peptidomimetics Containing 2-Oxo-1,3-oxazolidine-4-carboxylic Acids 87
Easy preparation of dehydroalanine building blocks equipped with oxazolidin-2-one chiral auxiliaries, and applications to the stereoselective synthesis of substituted tryptophans 87
Synthesis and Analysis of the Conformational Preferences of 5- Aminomethyloxazolidine-2,4-dione Scaffolds: First Examples of beta2- and beta2,2-Homo-Freidinger Lactam Analogues 86
Synthesis and Conformational Analysis of Cyclotetrapeptide Mimetic beta-Turn Templates and Validation as 3D Scaffolds 86
Interactions between atypical opioid agonists and MOR 86
Re-discussion of the importance of ionic interactions in stabilizing ligand-opioid receptor complex and in activating signal transduction 85
Short peptidomimetics containing heterocyclic scaffolds as alpha-v-beta-3 integrins ligands. 85
Stereoselective Synthesis of Linear and Cyclic Dehydro-beta-amino Acids for the Preparation of alpha-v-beta-3 and alpha-5-beta-1 Integrin Inhibitors 84
Alkylidene malonamides and acetacetamides as intermediates for the preparation of constrained dipeptide mimetics. 84
Tryptophan-Containing Non-Cationizable Opioid Peptides - A new chemotype with unusual structure and in vivo activity 84
Totale 11.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.539 0 0 0 186 291 272 384 436 400 258 93 219
2020/20212.201 420 122 101 153 41 113 146 170 229 125 134 447
2021/20222.705 343 155 186 132 262 146 95 294 107 148 409 428
2022/20233.089 264 447 156 382 224 261 119 161 592 91 236 156
2023/20241.376 91 135 80 119 169 284 101 98 43 99 83 74
2024/20251.271 192 599 379 101 0 0 0 0 0 0 0 0
Totale 15.154